Sintx Technologies (SINT) Current Deferred Revenue (2013 - 2018)
Sintx Technologies' quarterly Current Deferred Revenue came in at $169000.0 in Q4 2018, up 196.49% quarter-over-quarter from $57000.0 in Q4 2014.
Sintx Technologies has reported Current Deferred Revenue for 3 years, with the latest figure at $169000.0 in Q4 2018.
- For the quarter ending Q4 2018, Current Deferred Revenue changed N/A year-over-year to $169000.0; the trailing twelve-month figure through Dec 2018 stood at $169000.0 (changed N/A YoY), and the FY2018 full-year result was $169000.0, changed N/A from the prior year.
- Current Deferred Revenue for Q4 2018 stood at $169000.0, up from $57000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $169000.0 in Q4 2018, with the low at $37000.0 in Q1 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 169,000.00 |
| Dec 31, 2014 | 57,000.00 |
| Sep 30, 2014 | 50,000.00 |
| Jun 30, 2014 | 43,000.00 |
| Mar 31, 2014 | 37,000.00 |
| Dec 31, 2013 | 32,000.00 |